Inspire(US:INSP) Prnewswire·2025-12-22 09:00Core Viewpoint - Inspire Medical Systems, Inc. is facing allegations of misleading investors regarding the launch of its new product, Inspire V, which reportedly failed due to poor demand and inadequate preparations [1]. Group 1: Allegations and Issues - The complaint alleges that the launch of Inspire V was a disaster, with significant surplus inventory at treatment centers and reluctance from providers to adopt the new treatment [1]. - Defendants are accused of making false statements about the successful launch, while failing to complete essential tasks such as training for treatment center customers and setting up necessary IT systems [1]. - Critical issues included the lack of updates to insurer claims software and the absence of Medicare reimbursement at the time of launch, which were fundamental for the product's success [1]. Group 2: Class Action Details - Shareholders who purchased shares of INSP between August 6, 2024, and August 4, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for January 5, 2026 [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress, with no cost or obligation to join [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflated stock prices [3].